BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 12218160)

  • 1. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
    Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
    J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides.
    Xu MQ; Suo YP; Gong JP; Zhang MM; Yan LN
    World J Gastroenterol; 2004 Aug; 10(16):2361-8. PubMed ID: 15285020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity.
    Tiao MM; Lu L; Tao R; Wang L; Fung JJ; Qian S
    Ann Surg; 2005 Mar; 241(3):497-505. PubMed ID: 15729074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides.
    Giannoukakis N; Bonham CA; Qian S; Chen Z; Peng L; Harnaha J; Li W; Thomson AW; Fung JJ; Robbins PD; Lu L
    Mol Ther; 2000 May; 1(5 Pt 1):430-7. PubMed ID: 10933964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.
    Pearson TC; Alexander DZ; Hendrix R; Elwood ET; Linsley PS; Winn KJ; Larsen CP
    Transplantation; 1996 Apr; 61(7):997-1004. PubMed ID: 8623206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.
    Lan YY; Wang Z; Raimondi G; Wu W; Colvin BL; de Creus A; Thomson AW
    J Immunol; 2006 Nov; 177(9):5868-77. PubMed ID: 17056511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transduction of dendritic cells with adenoviral vectors encoding CTLA4-Ig markedly reduces their allostimulatory activity.
    Lu L; Lee WC; Gambotto A; Zhong C; Robbins PD; Qian S; Fung JJ; Thomson AW
    Transplant Proc; 1999; 31(1-2):797. PubMed ID: 10083343
    [No Abstract]   [Full Text] [Related]  

  • 9. Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cells.
    Xu DL; Liu Y; Tan JM; Li B; Zhong CP; Zhang XH; Wu CQ; Tang XD
    Scand J Immunol; 2004 Jun; 59(6):536-44. PubMed ID: 15182248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
    Guillot C; Mathieu P; Coathalem H; Le Mauff B; Castro MG; Tesson L; Usal C; Laumonier T; Brouard S; Soulillou JP; Lowenstein PR; Cuturi MC; Anegon I
    J Immunol; 2000 May; 164(10):5258-68. PubMed ID: 10799887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival.
    Takayama T; Kaneko K; Morelli AE; Li W; Tahara H; Thomson AW
    Transplantation; 2002 Jul; 74(1):112-9. PubMed ID: 12134108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation.
    Penna G; Adorini L
    J Immunol; 2000 Mar; 164(5):2405-11. PubMed ID: 10679076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time.
    Wang Z; Castellaneta A; De Creus A; Shufesky WJ; Morelli AE; Thomson AW
    J Immunol; 2004 May; 172(10):5924-30. PubMed ID: 15128773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus.
    Tao R; Wang L; Chen CH; Wang SH; Demarco RA; Lotze MT; Thai NL; Fung JJ; Lu L; Qian S
    J Heart Lung Transplant; 2006 Mar; 25(3):310-9. PubMed ID: 16507425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival.
    Min WP; Gorczynski R; Huang XY; Kushida M; Kim P; Obataki M; Lei J; Suri RM; Cattral MS
    J Immunol; 2000 Jan; 164(1):161-7. PubMed ID: 10605007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
    Tiao MM; Lu L; Tao R; Harnaha J; Fung JJ; Huang LT; Qian S
    Transplant Proc; 2004 Jun; 36(5):1592-4. PubMed ID: 15251391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice.
    Yang DF; Qiu WH; Zhu HF; Lei P; Wen X; Dai H; Zhou W; Shen GX
    Transpl Immunol; 2008 Jul; 19(3-4):197-201. PubMed ID: 18667318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
    Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
    J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
    Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
    Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity.
    Chen Z; Lu L; Zhang H; Dean NM; Fung JJ; Qian S
    Microsurgery; 2003; 23(5):494-7. PubMed ID: 14558009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.